Gene-Guided dosing may improve TB prevention
NCT ID NCT05413551
First seen Jan 05, 2026 · Last updated May 22, 2026 · Updated 22 times
Summary
This study tested whether adjusting the dose of a tuberculosis (TB) prevention drug based on a person's genetic makeup could improve treatment. Researchers gave 73 people at risk for TB a genetic test to guide their isoniazid dose. The goal was to see if this personalized approach leads to better drug levels in the blood, potentially making prevention safer and more effective.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TUBERCULOSIS INFECTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Federal University of Mato Grosso do Sul
Campo Grande, Mato Grosso do Sul, Brazil
Conditions
Explore the condition pages connected to this study.